Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANAB
#2123
AnaptysBio, Inc. - Common Stock
57.7
9
USD
+0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.74%
Monthly Change
+2.79%
6 month change
+4.46%
Year Change
+64.18%
Previous Close
56.8
0
Open
56.9
7
Low
56.8
3
High
57.8
3
Volume
309
Markets
US Stock Market
Healthcare
Biotechnology
ANAB
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
2017
Current report, 08 Mar 2017
2017.03.08
ANAPTYSBIO, INC current report, 08 March 2017
8-K
Current report, 24 Feb 2017
2017.03.02
ANAPTYSBIO, INC current report, 24 February 2017
8-K
2016
Annual report, Q4 FY2016
2017.03.08
ANAPTYSBIO, INC annual report, Q4 FY2016
10-K
1
...
6
7
8
9
10
11
12
13
News
GSK's sBLA for Jemperli Gets FDA Priority Tag in Rectal Cancer
AnaptysBio Stock: The Royalty Waterfall Is About To Reverse (NASDAQ:ANAB)
GSK's Jemperli Delivers Promising Interim Data in Rectal Cancer
Nvidia Releases First Full-Stack Safety System for Robot 'Physical AI' Halos for Robotics
Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year?
Wall Street Analysts See a 38.75% Upside in AnaptysBio (ANAB): Can the Stock Really Move This High?
Forte Biosciences Stock: Targeting Celiac Disease (NASDAQ:FBRX)
AnaptysBio (ANAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
RCKT Stock Down on Q1 Earnings Miss, Kresladi Launch in Focus
Why These Four Biotech Stocks Prove That Follow-On Entries Still Pop Up In Stock Market Leaders
Nektar Q1 Earnings & Revenues Lag Estimates, Pipeline in Focus
PBYI Q1 Earnings & Sales Beat Estimates, 2026 Guidance Raised